银化物Rb1促进肝糖原合成通过15-PGDH/PGE/EP4信号通路改善T2DM

相关实验视频

Updated: Jul 12, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

Mingjie Liang^1,2, Wenjing Zhan^1,2, Lexun Wang^1,2

¹Traditional Chinese Medicine Research Institute, Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, People's Republic of China.

Diabetes, metabolic syndrome and obesity : targets and therapy

|October 23, 2023

概括

银化物Rb1通过调节15-基前列腺素脱酶 (15-PGDH) /前列腺素E2 (PGE2) 途径来增强肝脏糖原生成,为2型糖尿病 (T2DM) 提供了一种新的治疗方法. 这种机制改善了肝脏的糖原合成,这对于管理T2DM至关重要.

科学领域:

生物化学生物化学
药理学药理学是指药理学的学科.
内分泌学在内分泌学.

背景情况:

帕纳克斯人参中的金赛诺化物Rb1 (Rb1) 显示出抗2型糖尿病 (T2DM) 的潜力.
在肝脏糖原生产中Rb1的机制,这是T2DM的关键,尚未完全理解.
15-基前列腺素脱酶 (15-PGDH) 禁用前列腺素E2 (PGE2);其抑制促进肝脏糖原合成.

研究的目的:

通过15-PGDH/PGE2通路调节肝脏糖原合成,研究Rb1是否能改善T2DM.
探索Rb1在调节T2DM中的15-PGDH和PGE2水平中的作用.
阐明参与Rb1-介导的糖原合成的下游信号通路.

主要方法:

建立了一个T2DM小鼠模型,使用链毒素和高脂肪饮食.
给T2DM小鼠服用Rb1或甲福明,持续8周.
利用体外抗胰岛素细胞模型和分子对接来评估Rb1-15-PGDH相互作用和途径调制.

主要成果:

Rb1增加了AKT和GSK3β的酸化,增强了T2DM小鼠的肝脏糖原合成.
分子对接证实了Rb1和15-PGDH之间的高结合亲和力.
Rb1抑制了升高的15-PGDH,并增加了降低的PGE2水平,这表明15-PGDH/PGE2/EP4通路的调节.

结论:

Rb1通过15-PGDH-依赖的途径增强肝脏糖原的产生,改善T2DM.
这项研究为Rb1在T2DM中的疗效提供了新的机制性解释.
Rb1显示出作为T2DM有效治疗剂的潜力.

关键词:

15基前列腺蛋白脱酶15-基前列腺素脱酶.人参化物 Rb1 肝脏糖原合成的方法的前列腺素E2E2的前列腺素.2型糖尿病是什么?

更多相关视频

Extraction and Analysis of Taiwanese Green Propolis

Extraction and Analysis of Taiwanese Green Propolis

Published on: January 7, 2019

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

相关概念视频

Insulin: The Receptor and Signaling Pathways

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

Hormones Regulating Blood Glucose

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Cell Specific Gene Expression

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...

cAMP-dependent Protein Kinase Pathways

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...